PubMed

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.

Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, Hadziyannis SJ, Marcellin P.

Hepatology. 2009 Sep 29. [Epub ahead of print]PMID: 19918980 [PubMed - as supplied by publisher]Related articles

Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients.

Reddy KR, Messinger D, Popescu M, Hadziyannis SJ.

J Viral Hepat. 2009 Oct;16(10):724-31.PMID: 19486469 [PubMed - indexed for MEDLINE]Related articles

Nonalcoholic fatty liver disease: from clinical recognition to treatment.

Sevastianos VA, Hadziyannis SJ.

Expert Rev Gastroenterol Hepatol. 2008 Feb;2(1):59-79. Review.PMID: 19072371 [PubMed - indexed for MEDLINE]Related articles

Telbivudine in the treatment of chronic hepatitis B.

Hadziyannis SJ, Vassilopoulos D.

Expert Rev Gastroenterol Hepatol. 2008 Feb;2(1):13-22. Review.PMID: 19072366 [PubMed - indexed for MEDLINE]Related articles

Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirin.

Reau N, Hadziyannis SJ, Messinger D, Fried MW, Jensen DM.

Am J Gastroenterol. 2008 Aug;103(8):1981-8.PMID: 18796095 [PubMed - indexed for MEDLINE]Related articlesFree article

Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B.

Vassilopoulos D, Rapti I, Nikolaou M, Hadziyannis E, Hadziyannis SJ.

J Viral Hepat. 2008 Nov;15(11):817-26. Epub 2008 Jun 11.PMID: 18554242 [PubMed - indexed for MEDLINE]Related articles

The role of entecavir in the treatment of chronic hepatitis B.

Dimou E, Papadimitropoulos V, Hadziyannis SJ.

Ther Clin Risk Manag. 2007 Dec;3(6):1077-86.PMID: 18516259 [PubMed - in process]Related articlesFree article

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.

Reddy KR, Govindarajan S, Marcellin P, Bernstein D, Dienstag JL, Bodenheimer H Jr, Rakela J, Messinger D, Schmidt G, Ackrill A, Hadziyannis SJ.

J Viral Hepat. 2008 Feb;15(2):129-36.PMID: 18184196 [PubMed - indexed for MEDLINE]Related articles

Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.

Deutsch M, Papatheodoridis GV, Tzakou A, Hadziyannis SJ.

Eur J Gastroenterol Hepatol. 2008 Jan;20(1):5-9.PMID: 18090982 [PubMed - indexed for MEDLINE]Related articles

Old and emerging therapies in chronic hepatitis C: an update.

Deutsch M, Hadziyannis SJ.

J Viral Hepat. 2008 Jan;15(1):2-11. Review.PMID: 18088238 [PubMed - indexed for MEDLINE]Related articles

Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.

Snoeck E, Hadziyannis SJ, Puoti C, Swain MG, Berg T, Marcellin P, Zarski JP, Jorga K, Zeuzem S.

Liver Int. 2008 Jan;28(1):61-71. Epub 2007 Oct 25.PMID: 17971091 [PubMed - indexed for MEDLINE]Related articles

Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".

Hadziyannis SJ.

Hepatol Int. 2007 Jun;1(2):281-4. No abstract available. PMID: 19669350 [PubMed - in process]Related articlesFree article

Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels.

Manesis EK, Hadziyannis ES, Angelopoulou OP, Hadziyannis SJ.

Antivir Ther. 2007;12(1):73-82.PMID: 17503750 [PubMed - indexed for MEDLINE]Related articles

Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients.

Hadziyannis SJ.

Expert Opin Investig Drugs. 2007 Jun;16(6):777-86. Review.PMID: 17501691 [PubMed - indexed for MEDLINE]Related articles

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin.

Foster GR, Fried MW, Hadziyannis SJ, Messinger D, Freivogel K, Weiland O.

Scand J Gastroenterol. 2007 Feb;42(2):247-55.PMID: 17327945 [PubMed - indexed for MEDLINE]Related articles

Acute rhabdomyolysis following quail consumption.

Papanikolaou IS, Dourakis SP, Papadimitropoulos VS, Hadziyannis SJ.

Ann Saudi Med. 2001 May-Jul;21(3-4):219-20. No abstract available. PMID: 17264558 [PubMed]Related articles

Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.

Rapti I, Dimou E, Mitsoula P, Hadziyannis SJ.

Hepatology. 2007 Feb;45(2):307-13.PMID: 17256746 [PubMed - indexed for MEDLINE]Related articles

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Brosgart CL, Borroto-Esoda K, Arterburn S, Chuck SL; Adefovir Dipivoxil 438 Study Group.

Gastroenterology. 2006 Dec;131(6):1743-51. Epub 2006 Sep 20.PMID: 17087951 [PubMed - indexed for MEDLINE]Related articles

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.

Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ.

Hepatology. 2006 Sep;44(3):694-702.PMID: 16941694 [PubMed - indexed for MEDLINE]Related articles

New developments in the treatment of chronic hepatitis B.

Hadziyannis SJ.

Expert Opin Biol Ther. 2006 Sep;6(9):913-21. Review.PMID: 16918258 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.

Hadziyannis SJ, Papatheodoridis GV.

Semin Liver Dis. 2006 May;26(2):130-41. Review.PMID: 16673291 [PubMed - indexed for MEDLINE]Related articles

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy.

Jensen DM, Morgan TR, Marcellin P, Pockros PJ, Reddy KR, Hadziyannis SJ, Ferenci P, Ackrill AM, Willems B.

Hepatology. 2006 May;43(5):954-60. Erratum in: Hepatology. 2006 Jun;43(6):1410. PMID: 16628671 [PubMed - indexed for MEDLINE]Related articles

Chronic hepatitis B: a critical appraisal of current approaches to therapy.

Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):233-48.PMID: 16469685 [PubMed - indexed for MEDLINE]Related articles

A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B.

Manesis EK, Papatheodoridis GV, Hadziyannis SJ.

Aliment Pharmacol Ther. 2006 Jan 1;23(1):99-106.PMID: 16393286 [PubMed - indexed for MEDLINE]Related articlesFree article

A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.

Chang TT, Gish RG, Hadziyannis SJ, Cianciara J, Rizzetto M, Schiff ER, Pastore G, Bacon BR, Poynard T, Joshi S, Klesczewski KS, Thiry A, Rose RE, Colonno RJ, Hindes RG; BEHoLD Study Group.

Gastroenterology. 2005 Oct;129(4):1198-209.PMID: 16230074 [PubMed - indexed for MEDLINE]Related articles

Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece.

Savvas SP, Koskinas J, Sinani C, Hadziyannis A, Spanou F, Hadziyannis SJ.

J Viral Hepat. 2005 Sep;12(5):551-7.PMID: 16108773 [PubMed - indexed for MEDLINE]Related articles

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Arterburn S, Xiong S, Currie G, Brosgart CL; Adefovir Dipivoxil 438 Study Group.

N Engl J Med. 2005 Jun 30;352(26):2673-81.PMID: 15987916 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.

Papatheodoridis GV, Dimou E, Dimakopoulos K, Manolakopoulos S, Rapti I, Kitis G, Tzourmakliotis D, Manesis E, Hadziyannis SJ.

Hepatology. 2005 Jul;42(1):121-9.PMID: 15962291 [PubMed - indexed for MEDLINE]Related articles

Emerging treatments in chronic hepatitis B.

Hadziyannis SJ, Papatheodoridis GV.

Expert Opin Emerg Drugs. 2004 Nov;9(2):207-21. Review.PMID: 15571480 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.

Hadziyannis SJ, Papatheodoridis GV.

Expert Rev Anti Infect Ther. 2004 Aug;2(4):475-83. Review.PMID: 15482214 [PubMed - indexed for MEDLINE]Related articles

Treatment of chronic hepatitis C infection with peginterferons plus ribavirin.

Fried MW, Hadziyannis SJ.

Semin Liver Dis. 2004;24 Suppl 2:47-54. Review.PMID: 15346246 [PubMed - indexed for MEDLINE]Related articles

Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies.

Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, Brosgart CL, Westland C, Arterbrun S, Deray G; Adefovir Dipivoxil International 437 Study Group; Adefovir Dipivoxil International 438 Study Group.

Kidney Int. 2004 Sep;66(3):1153-8.PMID: 15327411 [PubMed - indexed for MEDLINE]Related articles

Acute chest syndrome in sickle-cell trait; Two case reports in persons of Mediterranean origin and review of the literature.

Dourakis SP, Alexopoulou A, Papageorgiou C, Kaloterakis A, Hadziyannis SJ.

Eur J Intern Med. 2004 Jul;15(4):248-250.PMID: 15288680 [PubMed - as supplied by publisher]Related articles

Differences in epidemiology, liver disease and treatment response among HCV genotypes.

Hadziyannis SJ, Koskinas JS.

Hepatol Res. 2004 Jul;29(3):129-135. No abstract available. PMID: 15203075 [PubMed - as supplied by publisher]Related articles

Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.

Papatheodoridis GV, Papadelli D, Cholongitas E, Vassilopoulos D, Mentis A, Hadziyannis SJ.

Am J Med. 2004 May 1;116(9):601-5.PMID: 15093756 [PubMed - indexed for MEDLINE]Related articles

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM; PEGASYS International Study Group.

Ann Intern Med. 2004 Mar 2;140(5):346-55.PMID: 14996676 [PubMed - indexed for MEDLINE]Related articlesFree article

Precore mutant chronic hepatitis B - approach to management.

Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D.

MedGenMed. 2003 Oct 1;5(4):1. Review. No abstract available. PMID: 14745348 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others).

Hadziyannis SJ, Papatheodoridis GV.

J Hepatol. 2003;39 Suppl 1:S172-6. Review. No abstract available. PMID: 14708699 [PubMed - indexed for MEDLINE]Related articles

Review article: current management of chronic hepatitis B.

Papatheodoridis GV, Hadziyannis SJ.

Aliment Pharmacol Ther. 2004 Jan 1;19(1):25-37. Review.PMID: 14687164 [PubMed - indexed for MEDLINE]Related articlesFree article

Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.

Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ.

Am J Gastroenterol. 2003 Oct;98(10):2261-7.PMID: 14572577 [PubMed - indexed for MEDLINE]Related articles

Deep jaundice in an adolescent.

Deutsch M, Dourakis SP, Sevastianos VA, Kaloterakis A, Hadziyannis SJ.

Postgrad Med J. 2003 Sep;79(935):544, 548-9. No abstract available. PMID: 13679562 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment options for chronic hepatitis B not responding to interferon.

Hadziyannis SJ.

J Hepatol. 2003 Jun;38(6):853-5. Review. No abstract available. PMID: 12763382 [PubMed - indexed for MEDLINE]Related articles

Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.

Hadziyannis SJ, Papatheodoridis GV.

Expert Opin Pharmacother. 2003 Apr;4(4):541-51. Review.PMID: 12667117 [PubMed - indexed for MEDLINE]Related articles

Treatment of HBeAg-negative chronic hepatitis B.

Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D.

Semin Liver Dis. 2003 Feb;23(1):81-8. Review.PMID: 12616453 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL; Adefovir Dipivoxil 438 Study Group.

N Engl J Med. 2003 Feb 27;348(9):800-7. Erratum in: N Engl J Med. 2003 Mar 20;348(12):1192. PMID: 12606734 [PubMed - indexed for MEDLINE]Related articlesFree article

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, Hadziyannis SJ.

Gut. 2003 Mar;52(3):404-9.PMID: 12584224 [PubMed - indexed for MEDLINE]Related articlesFree article

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial.

Papatheodoridis GV, Hadziyannis ES, Deutsch M, Hadziyannis SJ.

Am J Gastroenterol. 2002 Aug;97(8):2063-70.PMID: 12190178 [PubMed - indexed for MEDLINE]Related articles

Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease.

Papatheodoridis GV, Dimou E, Laras A, Papadimitropoulos V, Hadziyannis SJ.

Hepatology. 2002 Jul;36(1):219-26.PMID: 12085368 [PubMed - indexed for MEDLINE]Related articles

Acute hepatitis associated with herb (Teucrium capitatum L.) administration.

Dourakis SP, Papanikolaou IS, Tzemanakis EN, Hadziyannis SJ.

Eur J Gastroenterol Hepatol. 2002 Jun;14(6):693-5.PMID: 12072605 [PubMed - indexed for MEDLINE]Related articles

Serum HBV-DNA levels in inactive hepatitis B virus carriers.

Manesis EK, Papatheodoridis GV, Hadziyannis SJ.

Gastroenterology. 2002 Jun;122(7):2092-3; author reply 2093. No abstract available. PMID: 12055617 [PubMed - indexed for MEDLINE]Related articles